Mao-Draayer Y - Search Results

1

Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies.

Amezcua L, Mao-Draayer Y, Vargas WS, Farber R, Schaefer S, Branco F, England SM, Belviso N, Lewin JB, Mendoza JP, Shankar SL; ENDORSE Study Investigators. Amezcua L, et al. Neurol Ther. 2023 Jun;12(3):883-897. doi: 10.1007/s40120-023-00475-8. Epub 2023 Apr 15. Neurol Ther. 2023. PMID: 37061656 Free PMC article.

2

Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) regulate murine neural progenitor cell survival, proliferation, and differentiation.

Scharf E, May V, Braas KM, Shutz KC, Mao-Draayer Y. Scharf E, et al. J Mol Neurosci. 2008 Nov;36(1-3):79-88. doi: 10.1007/s12031-008-9097-z. Epub 2008 Jul 15. J Mol Neurosci. 2008. PMID: 18629655 Free PMC article.

3

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.

Lundy SK, Wu Q, Wang Q, Dowling CA, Taitano SH, Mao G, Mao-Draayer Y. Lundy SK, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Mar 3;3(2):e211. doi: 10.1212/NXI.0000000000000211. eCollection 2016 Apr. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27006972 Free PMC article.

4

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.

Mills EA, Ogrodnik MA, Plave A, Mao-Draayer Y. Mills EA, et al. Front Neurol. 2018 Jan 23;9:5. doi: 10.3389/fneur.2018.00005. eCollection 2018. Front Neurol. 2018. PMID: 29410647 Free PMC article. Review.

5

Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity.

Longbrake EE, Mao-Draayer Y, Cascione M, Zielinski T, Bame E, Brassat D, Chen C, Kapadia S, Mendoza JP, Miller C, Parks B, Xing D, Robertson D. Longbrake EE, et al. Mult Scler. 2021 May;27(6):883-894. doi: 10.1177/1352458520937282. Epub 2020 Jul 27. Mult Scler. 2021. PMID: 32716690 Free PMC article. Clinical Trial.

6

Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.

Jordan AL, Yang J, Fisher CJ, Racke MK, Mao-Draayer Y. Jordan AL, et al. Mult Scler. 2022 Jan;28(1):7-15. doi: 10.1177/1352458520949158. Epub 2020 Aug 18. Mult Scler. 2022. PMID: 32808554 Free PMC article. Review.

7

Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.

Wu Q, Wang Q, Mao G, Dowling CA, Lundy SK, Mao-Draayer Y. Wu Q, et al. J Immunol. 2017 Apr 15;198(8):3069-3080. doi: 10.4049/jimmunol.1601532. Epub 2017 Mar 3. J Immunol. 2017. PMID: 28258191 Free PMC article.

8

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.

Mills EA, Mirza A, Mao-Draayer Y. Mills EA, et al. Front Neurol. 2017 Mar 29;8:116. doi: 10.3389/fneur.2017.00116. eCollection 2017. Front Neurol. 2017. PMID: 28424654 Free PMC article. Review.

9

Assessment and Treatment Strategies for a Multiple Sclerosis Relapse.

Wang C, Ruiz A, Mao-Draayer Y. Wang C, et al. J Immunol Clin Res. 2018;5(1):1032. Epub 2016 Dec 7. J Immunol Clin Res. 2018. PMID: 30417033 Free PMC article.

10

Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders.

Abboud H, Salazar-Camelo A, George N, Planchon SM, Matiello M, Mealy MA, Goodman A; On-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium. Abboud H, et al. J Neurol. 2022 Apr;269(4):1786-1801. doi: 10.1007/s00415-021-10783-4. Epub 2021 Sep 5. J Neurol. 2022. PMID: 34482456 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page